| Year |
Citation |
Score |
| 2020 |
Reuland CJ, Church FC. Synergy between plasminogen activator inhibitor-1, α-synuclein, and neuroinflammation in Parkinson's disease. Medical Hypotheses. 138: 109602. PMID 32035284 DOI: 10.1016/J.Mehy.2020.109602 |
0.329 |
|
| 2017 |
Serebruany VL, Kim MH, Kim SJ, Lee KM, Kim TH, Choi SY, Son MK, Park JW, Chen Q, Deng Y, Zhao S, Zhang D, Li X, Zhang Q, Qin Y, ... ... Church FC, et al. Contents Vol. 136, 2017 The Cardiology. 136. DOI: 10.1159/000454841 |
0.546 |
|
| 2016 |
Antoniak S, Cardenas JC, Buczek LJ, Church FC, Mackman N, Pawlinski R. Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation. Cardiology. 136: 258-268. PMID 27880950 DOI: 10.1159/000452269 |
0.642 |
|
| 2013 |
Cardenas JC, Aleman MM, Wang JG, Whinna HC, Wolberg AS, Church FC. Murine models do not recapitulate the pathophysiology of age-related venous thrombosis in humans. Journal of Thrombosis and Haemostasis : Jth. 11: 990-2. PMID 23480546 DOI: 10.1111/Jth.12189 |
0.572 |
|
| 2012 |
Wang JG, Geddings JE, Aleman MM, Cardenas JC, Chantrathammachart P, Williams JC, Kirchhofer D, Bogdanov VY, Bach RR, Rak J, Church FC, Wolberg AS, Pawlinski R, Key NS, Yeh JJ, et al. Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood. 119: 5543-52. PMID 22547577 DOI: 10.1182/Blood-2012-01-402156 |
0.661 |
|
| 2012 |
Carter JC, Church FC. Mature breast adipocytes promote breast cancer cell motility. Experimental and Molecular Pathology. 92: 312-7. PMID 22445926 DOI: 10.1016/J.Yexmp.2012.03.005 |
0.475 |
|
| 2012 |
Bompiani KM, Monroe DM, Church FC, Sullenger BA. A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity. Journal of Thrombosis and Haemostasis : Jth. 10: 870-80. PMID 22385910 DOI: 10.1111/J.1538-7836.2012.04679.X |
0.328 |
|
| 2012 |
Geddings JE, Wang J, Cardenas JC, Chantrathammachart P, Williams JC, Back RR, Church FC, Pawlinski R, Key N, Yeh JJ, Mackman N. Relationship between tissue factor expression by human pancreatic cancer cells and activation of coagulation and thrombosis in a mouse model. Journal of Clinical Oncology. 30. DOI: 10.1200/Jco.2012.30.15_Suppl.E14505 |
0.694 |
|
| 2012 |
Wang J, Gambone J, Aleman M, Cardenas J, Chantrathammachart P, Williams J, Kirchhofer D, Bogdanov V, Bach R, Church F, Wolberg A, Pawlinski R, Key N, Yeh J, Mackman N. Human pancreatic cancer cell tissue factor activates coagulation in a mousemodel Thrombosis Research. 129: S171. DOI: 10.1016/S0049-3848(12)70077-4 |
0.677 |
|
| 2011 |
Carter JC, Church FC. Peroxisome Proliferator-Activated Receptor-γ Ligands Alter Breast Cancer Cell Motility through Modulation of the Plasminogen Activator System. Journal of Oncology. 2011: 594258. PMID 22131991 DOI: 10.1155/2011/594258 |
0.442 |
|
| 2011 |
Rein CM, Cardenas JC, Church FC. The controversial role of the urokinase system in abdominal aortic aneurysm formation and rupture. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: 2769-71. PMID 22096092 DOI: 10.1161/Atvbaha.111.237123 |
0.656 |
|
| 2011 |
Rein CM, Desai UR, Church FC. Serpin-glycosaminoglycan interactions. Methods in Enzymology. 501: 105-37. PMID 22078533 DOI: 10.1016/B978-0-12-385950-1.00007-9 |
0.358 |
|
| 2011 |
Rau JC, Mitchell JW, Fortenberry YM, Church FC. Heparin cofactor II: discovery, properties, and role in controlling vascular homeostasis. Seminars in Thrombosis and Hemostasis. 37: 339-48. PMID 21805439 DOI: 10.1055/S-0031-1276582 |
0.786 |
|
| 2011 |
McEachron TA, Church FC, Mackman N. Regulation of thrombin-induced plasminogen activator inhibitor-1 in 4T1 murine breast cancer cells. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis. 22: 576-82. PMID 21799402 DOI: 10.1097/Mbc.0B013E3283497647 |
0.787 |
|
| 2011 |
Machlus KR, Cardenas JC, Church FC, Wolberg AS. Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. Blood. 117: 4953-63. PMID 21355090 DOI: 10.1182/Blood-2010-11-316885 |
0.63 |
|
| 2011 |
Fortenberry YM, Hlavacek AC, Church FC. Protein C inhibitor inhibits factor VIIa when bound to tissue factor. Journal of Thrombosis and Haemostasis : Jth. 9: 861-3. PMID 21251198 DOI: 10.1111/J.1538-7836.2011.04196.X |
0.346 |
|
| 2011 |
Cardenas JC, Owens AP, Krishnamurthy J, Sharpless NE, Whinna HC, Church FC. Overexpression of the cell cycle inhibitor p16INK4a promotes a prothrombotic phenotype following vascular injury in mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: 827-33. PMID 21233453 DOI: 10.1161/Atvbaha.110.221721 |
0.654 |
|
| 2010 |
McEachron TA, Pawlinski R, Richards KL, Church FC, Mackman N. Protease-activated receptors mediate crosstalk between coagulation and fibrinolysis. Blood. 116: 5037-44. PMID 20736455 DOI: 10.1182/Blood-2010-06-293126 |
0.757 |
|
| 2010 |
Fortenberry YM, Brandal S, Bialas RC, Church FC. Protein C inhibitor regulates both cathepsin L activity and cell-mediated tumor cell migration. Biochimica Et Biophysica Acta. 1800: 580-90. PMID 20230872 DOI: 10.1016/J.Bbagen.2010.03.003 |
0.478 |
|
| 2010 |
Carter JC, Campbell RA, Gibbons JA, Gramling MW, Wolberg AS, Church FC. Enhanced cell-associated plasminogen activator pathway but not coagulation pathway activity contributes to motility in metastatic breast cancer cells. Journal of Thrombosis and Haemostasis : Jth. 8: 1323-32. PMID 20180817 DOI: 10.1111/J.1538-7836.2010.03825.X |
0.817 |
|
| 2010 |
Gramling MW, Church FC. Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment. Thrombosis Research. 125: 377-81. PMID 20079523 DOI: 10.1016/J.Thromres.2009.11.034 |
0.808 |
|
| 2010 |
Gramling MW, Beaulieu LM, Church FC. Activated protein C enhances cell motility of endothelial cells and MDA-MB-231 breast cancer cells by intracellular signal transduction. Experimental Cell Research. 316: 314-28. PMID 19891966 DOI: 10.1016/J.Yexcr.2009.10.024 |
0.812 |
|
| 2010 |
McEachron T, Church F, Mackman N. Abstract 1251: Increased expression of the plasminogen activator system due to differential protease-activated receptor signaling in breast cancer cells Cancer Research. 70: 1251-1251. DOI: 10.1158/1538-7445.Am10-1251 |
0.784 |
|
| 2009 |
Rau JC, Deans C, Hoffman MR, Thomas DB, Malcom GT, Zieske AW, Strong JP, Koch GG, Church FC. Heparin cofactor II in atherosclerotic lesions from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Experimental and Molecular Pathology. 87: 178-83. PMID 19747479 DOI: 10.1016/J.Yexmp.2009.09.003 |
0.77 |
|
| 2009 |
Carter JC, Church FC. Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1. Ppar Research. 2009: 345320. PMID 19672469 DOI: 10.1155/2009/345320 |
0.437 |
|
| 2009 |
Carter JC, Campbell RA, Gibbons JA, Wolberg AS, Church FC. Enhanced Cell-Associated Fibrinolytic Pathway but Not Coagulation Pathway Activity Contributes to Motility in Metastatic Breast Cancer Cells. Blood. 114: 3170-3170. DOI: 10.1182/Blood.V114.22.3170.3170 |
0.461 |
|
| 2007 |
Gonzales PR, Walston TD, Camacho LO, Kielar DM, Church FC, Rezaie AR, Cooper ST. Mutation of the H-helix in antithrombin decreases heparin stimulation of protease inhibition. Biochimica Et Biophysica Acta. 1774: 1431-7. PMID 17905675 DOI: 10.1016/J.Bbapap.2007.08.020 |
0.317 |
|
| 2007 |
Beaulieu LM, Whitley BR, Wiesner TF, Rehault SM, Palmieri D, Elkahloun AG, Church FC. Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycle. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 29: 1029-38. PMID 17876797 DOI: 10.1002/Bies.20640 |
0.776 |
|
| 2007 |
Rau JC, Beaulieu LM, Huntington JA, Church FC. Serpins in thrombosis, hemostasis and fibrinolysis. Journal of Thrombosis and Haemostasis : Jth. 5: 102-15. PMID 17635716 DOI: 10.1111/J.1538-7836.2007.02516.X |
0.78 |
|
| 2007 |
Fortenberry YM, Whinna HC, Cooper ST, Myles T, Leung LLK, Church FC. Essential thrombin residues for inhibition by protein C inhibitor with the cofactors heparin and thrombomodulin Journal of Thrombosis and Haemostasis. 5: 1486-1492. PMID 17635698 DOI: 10.1111/J.1538-7836.2007.02574.X |
0.424 |
|
| 2007 |
Beaulieu LM, Church FC. Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1. Experimental Cell Research. 313: 677-87. PMID 17254565 DOI: 10.1016/J.Yexcr.2006.11.019 |
0.802 |
|
| 2007 |
Whitley BR, Beaulieu LM, Carter JC, Church FC. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells. Gynecologic Oncology. 104: 470-9. PMID 17070899 DOI: 10.1016/J.Ygyno.2006.08.048 |
0.79 |
|
| 2007 |
Fortenberry Y, Cook AB, Church FC. Inhibition of Factor VIIa-Tissue Factor by Protein C Inhibitor. Blood. 110: 1743-1743. DOI: 10.1182/Blood.V110.11.1743.1743 |
0.451 |
|
| 2007 |
Beaulieu LM, Gramling M, Church FC. Activated protein C has both extracellular and intracellular effects on breast cancer and endothelial cell migration The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A386-A |
0.793 |
|
| 2006 |
Beaulieu LM, Church FC. Is protein C inhibitor antithrombotic and protective in pulmonary hypertension? Journal of Thrombosis and Haemostasis : Jth. 4: 2327-30. PMID 16981887 DOI: 10.1111/J.1538-7836.2006.02214.X |
0.748 |
|
| 2006 |
Fortenberry Y, Bialas R, Mitchell C, Church FC. Regulation of Cathpsin L by the Serpin Protein C Inhibitor. Blood. 108: 336-336. DOI: 10.1182/Blood.V108.11.336.336 |
0.378 |
|
| 2005 |
Pike RN, Buckle AM, le Bonniec BF, Church FC. Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycans. The Febs Journal. 272: 4842-51. PMID 16176258 DOI: 10.1111/J.1742-4658.2005.04880.X |
0.39 |
|
| 2005 |
Whitley BR, Church FC. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1. International Journal of Oncology. 27: 749-57. PMID 16077925 DOI: 10.3892/Ijo.27.3.749 |
0.814 |
|
| 2005 |
Glasscock LN, Réhault SM, Gregory CW, Cooper ST, Jackson TP, Hoffman M, Church FC. Protein C inhibitor (plasminogen activator inhibitor-3) expression in the CWR22 prostate cancer xenograft. Experimental and Molecular Pathology. 79: 23-32. PMID 15878512 DOI: 10.1016/J.Yexmp.2005.02.008 |
0.31 |
|
| 2005 |
Réhault SM, Zechmeister-Machhart M, Fortenberry YM, Malleier J, Binz NM, Cooper ST, Geiger M, Church FC. Characterization of recombinant human protein C inhibitor expressed in Escherichia coli. Biochimica Et Biophysica Acta. 1748: 57-65. PMID 15752693 DOI: 10.1016/J.Bbapap.2004.12.003 |
0.446 |
|
| 2004 |
Hobson JP, Netzel-Arnett S, Szabo R, Réhault SM, Church FC, Strickland DK, Lawrence DA, Antalis TM, Bugge TH. Mouse DESC1 is located within a cluster of seven DESC1-like genes and encodes a type II transmembrane serine protease that forms serpin inhibitory complexes. The Journal of Biological Chemistry. 279: 46981-94. PMID 15328353 DOI: 10.1074/Jbc.M403299200 |
0.397 |
|
| 2004 |
Fortenberry YM, Whinna HC, Gentry HR, Myles T, Leung LL, Church FC. Molecular mapping of the thrombin-heparin cofactor II complex. The Journal of Biological Chemistry. 279: 43237-44. PMID 15292227 DOI: 10.1074/Jbc.M406716200 |
0.364 |
|
| 2004 |
Whinna HC, Lesesky EB, Monroe DM, High KA, Larson PJ, Church FC. Role of the γ-carboxyglutamic acid domain of activated factor X in the presence of calcium during inhibition by antithrombin-heparin Journal of Thrombosis and Haemostasis. 2: 1127-1134. PMID 15219196 DOI: 10.1111/J.1538-7836.2004.00796.X |
0.332 |
|
| 2004 |
Jeter ML, Ly LV, Fortenberry YM, Whinna HC, White RR, Rusconi CP, Sullenger BA, Church FC. RNA aptamer to thrombin binds anion-binding exosite-2 and alters protease inhibition by heparin-binding serpins. Febs Letters. 568: 10-4. PMID 15196911 DOI: 10.1016/J.Febslet.2004.04.087 |
0.32 |
|
| 2004 |
Whitley BR, Palmieri D, Twerdi CD, Church FC. Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cells. Experimental Cell Research. 296: 151-62. PMID 15149846 DOI: 10.1016/J.Yexcr.2004.02.022 |
0.808 |
|
| 2004 |
Fortenberry YM, Rau JC, Cranford LC, Myles T, Leung LL, Church FC. Essential Thrombin Residues for Inhibition by Plasminogen Activator Inhibitor-1 in the Absence and Presence of Heparin and Vitronectin. Blood. 104: 3986-3986. DOI: 10.1182/Blood.V104.11.3986.3986 |
0.789 |
|
| 2003 |
Hoffman M, Loh KLM, Bond VK, Palmieri D, Ryan JL, Church FC. Localization of heparin cofactor II in injured human skin: A potential role in wound healing Experimental and Molecular Pathology. 75: 109-118. PMID 14516771 DOI: 10.1016/S0014-4800(03)00073-X |
0.661 |
|
| 2003 |
Glasscock LN, Gerlitz B, Cooper ST, Grinnell BW, Church FC. Basic residues in the 37-loop of activated protein C modulate inhibition by protein C inhibitor but not by alpha(1)-antitrypsin. Biochimica Et Biophysica Acta. 1649: 106-17. PMID 12818196 DOI: 10.1016/S1570-9639(03)00164-X |
0.404 |
|
| 2003 |
Wu HM, Church FC. Arginine 25 and Arginine 28 of lactoferrin are critical for effective heparin neutralization in blood. Archives of Biochemistry and Biophysics. 412: 121-5. PMID 12646274 DOI: 10.1016/S0003-9861(03)00035-3 |
0.341 |
|
| 2003 |
Fortenberry Y, Ly L, Myles T, Leung LLK, Whinna HC, Church FC. Role of surface amino acid residues in thrombin essential for inhibition by antithrombin, heparin cofactor II and protein C inhibitor Journal of Thrombosis and Haemostasis. 1. DOI: 10.1111/J.1538-7836.2003.Tb05735.X |
0.344 |
|
| 2002 |
Bauman SJ, Whinna HC, Church FC. Serpins (serine protease inhibitors) Current Protocols in Protein Science / Editorial Board, John E. Coligan ... [Et Al.]. PMID 18429232 DOI: 10.1002/0471140864.Ps2107S26 |
0.362 |
|
| 2002 |
Cooper ST, Rezaie AR, Esmon CT, Church FC. Inhibition of a thrombin anion-binding exosite-2 mutant by the glycosaminoglycan-dependent serpins protein C inhibitor and heparin cofactor II. Thrombosis Research. 107: 67-73. PMID 12413592 DOI: 10.1016/S0049-3848(02)00180-9 |
0.33 |
|
| 2002 |
Palmieri D, Lee JW, Juliano RL, Church FC. Plasminogen activator inhibitor-1 and -3 increase cell adhesion and motility of MDA-MB-435 breast cancer cells. The Journal of Biological Chemistry. 277: 40950-7. PMID 12176977 DOI: 10.1074/Jbc.M202333200 |
0.765 |
|
| 2002 |
Baglin TP, Carrell RW, Church FC, Esmon CT, Huntington JA. Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism. Proceedings of the National Academy of Sciences of the United States of America. 99: 11079-84. PMID 12169660 DOI: 10.1073/Pnas.162232399 |
0.354 |
|
| 2002 |
Oliver JA, Monroe DM, Church FC, Roberts HR, Hoffman M. Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfaces. Blood. 100: 539-46. PMID 12091346 DOI: 10.1182/Blood.V100.2.539 |
0.374 |
|
| 2002 |
Mitchell JW, Church FC. Aspartic acid residues 72 and 75 and tyrosine-sulfate 73 of heparin cofactor II promote intramolecular interactions during glycosaminoglycan binding and thrombin inhibition. The Journal of Biological Chemistry. 277: 19823-30. PMID 11856753 DOI: 10.1074/Jbc.M200630200 |
0.421 |
|
| 2000 |
Holland CA, Henry AT, Whinna HC, Church FC. Effect of oligodeoxynucleotide thrombin aptamer on thrombin inhibition by heparin cofactor II and antithrombin Febs Letters. 484: 87-91. PMID 11068038 DOI: 10.1016/S0014-5793(00)02131-1 |
0.399 |
|
| 2000 |
Bushman JE, Palmieri D, Whinna HC, Church FC. Insight into the mechanism of asparaginase-induced depletion of antithrombin III in treatment of childhood acute lymphoblastic leukemia. Leukemia Research. 24: 559-65. PMID 10867129 DOI: 10.1016/S0145-2126(00)00017-5 |
0.69 |
|
| 2000 |
Shirk RA, Parthasarathy N, San Antonio JD, Church FC, Wagner WD. Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque. The Journal of Biological Chemistry. 275: 18085-92. PMID 10749870 DOI: 10.1074/Jbc.M001659200 |
0.413 |
|
| 1999 |
Bauman SJ, Church FC. Enhancement of heparin cofactor II anticoagulant activity Journal of Biological Chemistry. 274: 34556-34565. PMID 10574918 DOI: 10.1074/Jbc.274.49.34556 |
0.407 |
|
| 1998 |
Myles T, Church FC, Whinna HC, Monard D, Stone SR. Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes. The Journal of Biological Chemistry. 273: 31203-8. PMID 9813026 DOI: 10.1074/Jbc.273.47.31203 |
0.329 |
|
| 1998 |
Neese LL, Wolfe CA, Church FC. Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor. Archives of Biochemistry and Biophysics. 355: 101-108. PMID 9647672 DOI: 10.1006/Abbi.1998.0716 |
0.305 |
|
| 1998 |
Elisen MGLM, Bouma BN, Church FC, Meijers JCM. Inhibition of serine proteases by reactive site mutants of protein C inhibitor (plasminogen activator inhibitor-3) Fibrinolysis and Proteolysis. 12: 283-291. DOI: 10.1016/S0268-9499(98)80021-0 |
0.41 |
|
| 1997 |
Cooper ST, Church FC. PCI: Protein C Inhibitor? Advances in Experimental Medicine and Biology. 425: 45-54. PMID 9433488 DOI: 10.1007/978-1-4615-5391-5_5 |
0.385 |
|
| 1997 |
Jackson TP, Cooper ST, Church FC. Assessment of the interaction between urokinase and reactive site mutants of protein C inhibitor. Journal of Protein Chemistry. 16: 819-828. PMID 9365930 DOI: 10.1023/A:1026324102618 |
0.433 |
|
| 1997 |
Ciaccia AV, Monroe DM, Church FC. Arginine 200 of heparin cofactor II promotes intramolecular interactions of the acidic domain: Implication for thrombin inhibition Journal of Biological Chemistry. 272: 14074-14079. PMID 9162031 DOI: 10.1074/Jbc.272.22.14074 |
0.373 |
|
| 1997 |
Ciaccia AV, Willemze AJ, Church FC. Heparin Promotes Proteolytic Inactivation by Thrombin of a Reactive Site Mutant (L444R) of Recombinant Heparin Cofactor II Journal of Biological Chemistry. 272: 888-893. PMID 8995378 DOI: 10.1074/Jbc.272.2.888 |
0.314 |
|
| 1996 |
Shirk RA, Church FC, Wagner WD. Arterial Smooth Muscle Cell Heparan Sulfate Proteoglycans Accelerate Thrombin Inhibition by Heparin Cofactor II Arteriosclerosis, Thrombosis, and Vascular Biology. 16: 1138-1146. PMID 8792767 DOI: 10.1161/01.Atv.16.9.1138 |
0.395 |
|
| 1996 |
Kounnas MZ, Church FC, Argraves WS, Strickland DK. Cellular internalization and degradation of antithrombin III-thrombin, heparin cofactor II-thrombin, and alpha 1-antitrypsin-trypsin complexes is mediated by the low density lipoprotein receptor-related protein. The Journal of Biological Chemistry. 271: 6523-9. PMID 8626456 DOI: 10.1074/Jbc.271.11.6523 |
0.382 |
|
| 1996 |
Cooper ST, Neese LL, DiCuccio MN, Liles DK, Hoffman M, Church FC. Vascular Localization of the Heparin-binding Serpins Antithrombin, Heparin Cofactor II, and Protein C Inhibitor: Clinical and Applied Thrombosis-Hemostasis. 2: 185-191. DOI: 10.1177/107602969600200307 |
0.346 |
|
| 1996 |
Elisen MGLM, Maseland MHH, Church FC, Bouma BN, Meijers JCM. Role of the A+ helix in heparin binding to protein C inhibitor. Thrombosis and Haemostasis. 75: 760-766. DOI: 10.1055/S-0038-1650363 |
0.343 |
|
| 1995 |
Wu HF, Monroe DM, Church FC. Characterization of the Glycosaminoglycan-Binding Region of Lactoferrin Archives of Biochemistry and Biophysics. 317: 85-92. PMID 7872808 DOI: 10.1006/Abbi.1995.1139 |
0.321 |
|
| 1995 |
Cooper ST, Church FC. Reactive site mutants of recombinant protein C inhibitor Biochimica Et Biophysica Acta. 1246: 29-33. PMID 7811727 DOI: 10.1016/0167-4838(94)00185-J |
0.368 |
|
| 1995 |
Melton LG, Church FC, Erickson BW. Designed polyanionic coiled-coil proteins: acceleration of heparin cofactor II inhibition of thrombin. International Journal of Peptide and Protein Research. 45: 44-52. PMID 7775008 DOI: 10.1111/J.1399-3011.1995.Tb01566.X |
0.308 |
|
| 1995 |
Crago AM, Wu HF, Hoffman M, Church FC. Monocyte chemoattractant activity of Ser195 → Ala active site mutant recombinant α-thrombin Experimental Cell Research. 219: 650-656. PMID 7641816 DOI: 10.1006/Excr.1995.1275 |
0.382 |
|
| 1995 |
Rezaie AR, Cooper ST, Church FC, Esmon CT. Protein C Inhibitor Is a Potent Inhibitor of the Thrombin-Thrombomodulin Complex Journal of Biological Chemistry. 270: 25336-25339. PMID 7592694 DOI: 10.1074/Jbc.270.43.25336 |
0.399 |
|
| 1995 |
Cooper ST, Whinna HC, Jackson TP, Boyd JM, Church FC. Intermolecular interactions between protein C inhibitor and coagulation proteases Biochemistry. 34: 12991-12997. PMID 7548057 DOI: 10.1021/Bi00040A009 |
0.398 |
|
| 1995 |
Wu H, Lundblad RL, Church FC. Neutralization of heparin activity by neutrophil lactoferrin Blood. 85: 421-428. DOI: 10.1182/Blood.V85.2.421.Bloodjournal852421 |
0.408 |
|
| 1994 |
Church FC, Hoffman MR. Heparin cofactor II and thrombin Heparin-binding proteins linking hemostasis and inflammation. Trends in Cardiovascular Medicine. 4: 140-6. PMID 21244893 DOI: 10.1016/1050-1738(94)90066-3 |
0.354 |
|
| 1994 |
Neese LL, Pratt CW, Church FC. Modulation of protein C inhibitor activity. Blood Coagulation & Fibrinolysis. 5: 737-746. PMID 7532447 DOI: 10.1097/00001721-199410000-00010 |
0.438 |
|
| 1993 |
Whinna HC, Church FC. Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor. Journal of Protein Chemistry. 12: 677-688. PMID 8136018 DOI: 10.1007/Bf01024926 |
0.408 |
|
| 1991 |
Hoffman M, Faulkner KA, Iannone MA, Church FC. The effects of heparin cofactor II-derived chemotaxins on neutrophil actin conformation and cyclic AMP levels Bba - Molecular Cell Research. 1095: 78-82. PMID 1932129 DOI: 10.1016/0167-4889(91)90047-2 |
0.363 |
|
| 1990 |
Corbin LW, Church FC, Hoffman M. Production of chemotactic peptides by neutrophil degradation of heparin cofactor II. Thrombosis Research. 57: 77-85. PMID 2300926 DOI: 10.1016/0049-3848(90)90196-J |
0.395 |
|
| 1990 |
Hoffman M, Pratt CW, Corbin LW, Church FC. Characteristics of the chemotactic activity of heparin cofactor II proteolysis products Journal of Leukocyte Biology. 48: 156-162. PMID 2196322 DOI: 10.1002/Jlb.48.2.156 |
0.388 |
|
| 1989 |
Pratt CW, Macik BG, Church FC. Protein C inhibitor: Purification and proteinase reactivity Thrombosis Research. 53: 595-602. PMID 2544038 DOI: 10.1016/0049-3848(89)90149-7 |
0.376 |
|
| 1989 |
Hoffman M, Pratt C, Brown R, Church F. Heparin cofactor II-proteinase reaction products exhibit neutrophil chemoattractant activity Blood. 73: 1682-1685. DOI: 10.1182/Blood.V73.6.1682.1682 |
0.383 |
|
| 1988 |
Bradley Sherrill G, Meade JB, Kalayanamit T, Monroe DM, Church FC. Calcium enhances factor Xa activity independent of γ-carboxyglutamic acid residues Thrombosis Research. 52: 53-60. PMID 3201396 DOI: 10.1016/0049-3848(88)90040-0 |
0.301 |
|
| 1988 |
Church FC, Pratt CW, Treanor RE, Whinna HC. Antithrombin action of phosvitin and other phosphate-containing polyanions is mediated by heparin cofactor II. Febs Letters. 237: 26-30. PMID 3169238 DOI: 10.1016/0014-5793(88)80164-9 |
0.333 |
|
| 1987 |
Church FC, Treanor RE, Sherrill GB, Whinna HC. Carboxylate polyanions accelerate inhibition of thrombin by heparin cofactor II Biochemical and Biophysical Research Communications. 148: 362-368. PMID 3675584 DOI: 10.1016/0006-291X(87)91119-3 |
0.324 |
|
| 1987 |
Church FC, Meade JB, Pratt CW. Structure-function relationships in heparin cofactor II: spectral analysis of aromatic residues and absence of a role for sulfhydryl groups in thrombin inhibition Archives of Biochemistry and Biophysics. 259: 331-340. PMID 3426230 DOI: 10.1016/0003-9861(87)90499-1 |
0.333 |
|
| 1986 |
Church FC, Villanueva GB, Griffith MJ. Structure-function relationships in heparin cofactor II: Chemical modification of arginine and tryptophan and demonstration of a two-domain structure Archives of Biochemistry and Biophysics. 246: 175-184. PMID 3754413 DOI: 10.1016/0003-9861(86)90461-3 |
0.384 |
|
| 1985 |
Church FC, Lundblad RL, Noyes CM, Tarvers RC. Effect of divalent cations on the limited proteolysis of prothrombin by thrombin. Archives of Biochemistry and Biophysics. 240: 607-612. PMID 4026296 DOI: 10.1016/0003-9861(85)90067-0 |
0.315 |
|
| 1985 |
Church FC, Noyes CM, Griffith MJ. Inhibition of chymotrypsin by heparin cofactor II Proceedings of the National Academy of Sciences of the United States of America. 82: 6431-6434. PMID 3863104 DOI: 10.1073/Pnas.82.19.6431 |
0.357 |
|
| 1984 |
Church FC, Griffith MJ. Evidence for essential lysines in heparin cofactor II Biochemical and Biophysical Research Communications. 124: 745-751. PMID 6439196 DOI: 10.1016/0006-291X(84)91021-0 |
0.408 |
|
| Show low-probability matches. |